Development and pre-test of a risk benefit assessment tool to support programmatic decision-making regarding Plasmodium vivax radical cure treatment options in Latin America and The Caribbean

Krintafel (tafenoquine) - 60° Pharma

https://plan.core-apps.com/astmh24/abstract/b7e690ad-81ad-4551-b02f-411419f3becf

Xue Wu1; Sonia Herrera1; Corey Rathe1; Leopoldo Villegas1; Angela Devine2; Kamala Thriemer3; Ivan Cardenas4; Mario Olivera5; Maria Paz Ade6; Roberto Montoya6; michelle Hsiang1

Oct 11, 2024